Your address will show here +12 34 56 78

Featured —

Featured, Case study

In this use case, find out how MTP, a leading manufacturer of high-quality capital goods, specializes in industries such as aerospace, automotive and industrial manufacturing. What are MTP’s risks if it doesn’t have credit insurance? What does it risk in the event of default and non-payment by one of its strategic customers?◆ What is the context of the MTP company?◆ What are the risks for the MTP company?◆ How does the UNLOCK MULTI solution work?Download the PDF versionFollow us on LinkedIn for more information  

Continue Reading
Featured, Market Study

The landscape of automotive innovation has shifted over time. Since the invention of the automobile over a century ago, Europe played a pioneering but today has no longer its position of prominence.Indeed, in the early 2000s, China decided to go electric. But it’s only in 2015 the European Continent began its transition, confronted with:→ Volkswagen Emissions Scandal (Dieselgate),→ Rising Environmental Concerns and the Paris Climate Agreement.So today, the landscape for electric vehicles (EVs) is evolving, bringing both economic and political challenges.According to IEA, the surge in electric car sales during 2023SEE DETAILS <span class="more-link-hover-imag...

Continue Reading
Featured, Case study

In this case study, find out how a machine tool supplier, INDEX, limited its exposure to the risk of non-payment following the acceptance of a new order from its customer PEI, by integrating Unlock Focus as an additional solution to its credit management procedures. ◆ What is INDEX’s context?◆ What are the risks for INDEX?◆ How does the Unlock Focus solution work?Download the PDF versionFollow us on LinkedIn for more information

Continue Reading
Featured, Press Area

On 2 May, Cartan Trade announced the appointment of Sébastien Guidoni as its new CEO. With over 23 years’ experience in transformation and acceleration acquired in a wide variety of roles within major insurance groups and start-ups, this appointment promises to accelerate growth and open up new perspectives for the company—Sébastien Guidoni shares Cartan Trade’s new roadmap with us.When I joined Cartan Trade a few months ago as COO, and now as CEO, I was impressed by how quickly the company has grown after just 2 years in existence andSEE DETAILS

Continue Reading
Featured, Market Study

Pharmaceutical IndustryThe Covid-19 pandemic thrust the pharmaceutical industry into the spotlight, intensifying the pressure to deliver swift results. Since, companies faced a host of challenges.The pharma’s role within the healthcare system is weakening due to:–  A sudden surge in demand which encourages research and development, but that implies high financial burden–  Economic strains,– Suffocating regulatory change.To remain profitable, pharmaceutical companies need to change their operational strategy as the industry faces new challenges. This is what LloydsPharmacy, once the 2nd largest pharmacy chain in the UK, did but faced with aSEE DETAILS <span class="more...

Continue Reading
PREVIOUS POSTSPage 1 of 4NO NEW POSTS

Our News —

Featured

Unlock Multi – case study in customer portfolio concentration

11 July 2024

In this use case, find out how MTP, a leading manufacturer of high-quality capital goods, specializes in industries such as aerospace, automotive and ...

Featured

Automotive Industry – War of continents

11 July 2024

The landscape of automotive innovation has shifted over time. Since the invention of the automobile over a century ago, Europe played a pioneering but...

Featured

Single Risk – Case study

25 June 2024

In this case study, find out how a machine tool supplier, INDEX, limited its exposure to the risk of non-payment following the acceptance of a new ord...

Featured

A new roadmap for Cartan Trade

17 June 2024

On 2 May, Cartan Trade announced the appointment of Sébastien Guidoni as its new CEO. With over 23 years’ experience in transformation and accel...

Featured

Lloyds Pharmacy

13 June 2024

Pharmaceutical IndustryThe Covid-19 pandemic thrust the pharmaceutical industry into the spotlight, intensifying the pressure to deliver swift results...